Climb Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Climb Bio and other ETFs, options, and stocks.About CLYM
Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases.
CEOAoife M. Brennan
CEOAoife M. Brennan
Employees18
Employees18
HeadquartersWellesley Hills, Massachusetts
HeadquartersWellesley Hills, Massachusetts
Founded2018
Founded2018
Employees18
Employees18
CLYM Key Statistics
Market cap130.46M
Market cap130.46M
Price-Earnings ratio-2.77
Price-Earnings ratio-2.77
Dividend yield—
Dividend yield—
Average volume527.67K
Average volume527.67K
High today$1.98
High today$1.98
Low today$1.76
Low today$1.76
Open price$1.87
Open price$1.87
Volume297.24K
Volume297.24K
52 Week high$4.34
52 Week high$4.34
52 Week low$1.05
52 Week low$1.05
Stock Snapshot
Climb Bio(CLYM) stock is priced at $1.93, giving the company a market capitalization of 130.46M. It carries a P/E multiple of -2.77.
As of 2025-11-06, Climb Bio(CLYM) stock has fluctuated between $1.76 and $1.98. The current price stands at $1.93, placing the stock +9.4% above today's low and -2.5% off the high.
The Climb Bio(CLYM)'s current trading volume is 297.24K, compared to an average daily volume of 527.67K.
In the last year, Climb Bio(CLYM) shares hit a 52-week high of $4.34 and a 52-week low of $1.05.
In the last year, Climb Bio(CLYM) shares hit a 52-week high of $4.34 and a 52-week low of $1.05.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CLYM. This list is generated using Robinhood data, and it’s not a recommendation.